Electrical silencing of dendritic arborization neurons rescues toxic polyglutamine-induced locomotion defect

TL;DR

Silencing specific neurons in fruit fly larvae reversed movement problems caused by a toxic protein linked to Huntington’s disease.

Contribution

Electrical silencing of class IV da neurons rescues polyQ-induced locomotion defects in Drosophila larvae.

Findings

PolyQ expression in class IV da neurons caused slower crawling and increased turning in larvae.

Electrical silencing of these neurons reversed the locomotion deficits caused by polyQ.

The results suggest that modulating neuronal activity could be a therapeutic strategy for polyQ diseases.

Abstract

This study investigates the effects of polyglutamine (polyQ) expansions on the locomotion of Drosophila larvae, focusing on the role of class IV dendritic arborization (da) neurons. PolyQ expansions are associated with neurodegenerative diseases like Huntington’s disease, and Drosophila is a valuable model organism for studying these diseases due to its genetic tractability and short generation time. We found that expressing a polyQ protein in class IV da neurons caused significant locomotion deficits. Specifically, larvae with polyQ expression exhibited slower crawling speed and increased turn frequency, indicating impaired movement. The most intriguing finding of our study was that electrically silencing class IV da neurons completely rescued the locomotion deficits caused by polyQ expression. By expressing a potassium channel that makes the neurons less active, we effectively reversed the locomotion defects. This suggests that modulating the activity of these neurons could be a promising therapeutic approach for treating polyQ diseases. Our findings have significant implications for understanding polyQ diseases and developing new therapeutic approaches. By electrically silencing these neurons, we may be preventing the harmful effects of polyQ-induced cation channels, which are thought to disrupt cellular function. This opens up exciting possibilities for exploring electrical silencing as a potential treatment for polyQ diseases, offering hope for future therapies that target the underlying mechanisms of these devastating conditions.

Figures